YCharts Raises $6M for Sales Expansion

Increased investment will enable YCharts to build out its sales and account management functions to respond to growing demand.

jeremy-diamond-ycharts-morningstar-web-financial-group

The funding round was led by existing investor Morningstar, which maintains its 20 percent stake in the vendor, and also included significant investments from publisher Reed Elsevier, as well as private equity firms I2A, Amicus Capital Partners, Hyde Park Investors, and individual angel investors.

YCharts chief executive Shawn Carpenter says the vendor will use the new funds to accelerate an expansion of its sales force to target bigger, enterprise-level deals, after completing the build-out of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here